Advertisement

Topics

National Lung Cancer Partnership Company Profile

06:40 EST 23rd January 2019 | BioPortfolio

The National Lung Cancer Partnership is a 501(c)(3) non-profit organization made up of leading doctors, researchers, patient advocates, and lung cancer survivors dedicated to raising public awareness of the disease and generating funding for lung cancer research. For more information please visit NationalLungCancerPartnership.org


News Articles [4252 Associated News Articles listed on BioPortfolio]

Study Finds Lung Cancer Screening Guidelines Inadequate for High-Risk Minorities

Data from a lung cancer screening program at the University of Illinois at Chicago provides evidence that national lung cancer screening guidelines, which were developed based on the National Lung Scr...

Lung cancer screening guidelines may be insufficient for people in minority communities

Data from a lung cancer screening program at the University of Illinois at Chicago provides evidence that national lung cancer screening guidelines, which were developed based on the National Lung Scr...

Mirati Therapeutics joins Cancer Research UK’s Stratified Medicine Programme

Press release Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advan...

Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer

Source: National Cancer Institute - Related MedlinePlus Pages: Lung Cancer

Add Race to Lung Cancer Screening Criteria, Study Suggests

Lung cancer screening in an urban, largely black cohort yielded roughly double the rates of positive screens and lung cancers compared with results from the largely white National Lung Screening Trial...

Lung Cancer Tumor Markers

Source: National Library of Medicine - Related MedlinePlus Pages: Lung Cancer

Lung cancer screening guidelines inadequate for high-risk minorities

(University of Illinois at Chicago) Data from a Chicago-based lung cancer screening program provides evidence that national lung cancer screening guidelines may be insufficient for individuals in unde...

New lung cancer guides aim to drive better outcomes and care

Two new, national guides that aim to drive better outcomes and care for all people affected by lung cancer were released by Cancer Australia today. Lung cancer is the leading cause of death from cance...

Drugs and Medications [200 Associated Drugs and Medications listed on BioPortfolio]

Plavix [Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets, for oral use In...

Gemcitabine hydrochloride [BluePoint Laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for inje...

Gemcitabine [Fresenius Kabi USA, LLC]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABIN...

Gemcitabine [Fresenius Kabi USA, LLC]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

Oral-b neutra-foam mint [Oral-B Laboratories]

Package. Label Principal Display Panel

PubMed Articles [9213 Associated PubMed Articles listed on BioPortfolio]

The Partnership for Accelerating Cancer Therapies.

As a part of the Cancer Moonshot, the National Cancer Institute, part of the National Institutes of Health, the Foundation for National Institutes of Health, the US Food and Drug Administration, and 1...

Surgical Disparities among Patients with Stage I Lung Cancer in the National Lung Screening Trial.

Low-dose computed tomography (LDCT) reduces lung cancer mortality in high-risk patients fit to undergo surgical resection. Racial disparities in resection of lung cancer in non-screening populations a...

Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).

Accurate comorbidity measurement is critical for cancer research. We evaluated comorbidity assessment in the National Cancer Database (NCDB), which uses a code-based Charlson-Deyo Comorbidity Index (C...

An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.

While lung cancer screening has been implemented in the United States, it is still under consideration in Europe. So far, lung cancer screening trials in Europe were not able to replicate the results ...

Impact of organisation and specialist service delivery on lung cancer outcomes.

Data from the National Lung Cancer Audit (NLCA) often show variation in outcomes between lung cancer units which are not entirely explained by case mix. We explore the association between the organisa...

Clinical Trials [14609 Associated Clinical Trials listed on BioPortfolio]

A Retrospective Pharmacoeconomic Study of Lung Cancer

Lung cancer is the No. cause of cancer death in Taiwan. Yet most of lung cancer are diagnosed at late stage, not amenable to surgical resection. With the introduction of new targeted agent...

National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria

National, prospective, multicentric, non-interventional registry-based study, conducted among oncologists, pulmonologists in community and university hospitals, from the public sector in A...

Korean Lung Cancer Screening Project

Lung cancer is by far the leading cause of cancer death and has a lower relative survival rate than other types of cancer because most lung cancers are detected at an advanced stage when t...

Healthy Environments Partnership

The Healthy Environments Partnership was established in October 2000, as a part of the National Institute of Environmental Health Sciences “Health Disparities Initiative.” The Healthy...

Noninvasive vs. Invasive Lung Evaluation

Tumor derived cell free DNA (cfDNA) is increasingly used in the clinic to obtain genotype information about lung cancer, but its concordance with concurrent tumor-derived sequenced data is...

Companies [3211 Associated Companies listed on BioPortfolio]

National Lung Cancer Partnership

The National Lung Cancer Partnership is a 501(c)(3) non-profit organization made up of leading doctors, researchers, patient advocates, and lung cancer survivors dedicated to raising public awareness ...

GiveForward and Lung Cancer Alliance

GiveForward is the leading crowdfunding site focused on helping families and friends raise money to help offset a loved one’s medical bills. Co-founded in 2008 by Desi...

Bonnie J. Addario Lung Cancer Foundation (ALCF)

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating ...

Bonnie J Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Ca...

Oncimmune Holdings plc

Oncimmune is a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology. Oncimmune has pioneered the development of ...

More Information about "National Lung Cancer Partnership" on BioPortfolio

We have published hundreds of National Lung Cancer Partnership news stories on BioPortfolio along with dozens of National Lung Cancer Partnership Clinical Trials and PubMed Articles about National Lung Cancer Partnership for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Lung Cancer Partnership Companies in our database. You can also find out about relevant National Lung Cancer Partnership Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record